NO872541D0 - Fremgangsmaate ved fremstilling av immunomodulatorer. - Google Patents

Fremgangsmaate ved fremstilling av immunomodulatorer.

Info

Publication number
NO872541D0
NO872541D0 NO872541A NO872541A NO872541D0 NO 872541 D0 NO872541 D0 NO 872541D0 NO 872541 A NO872541 A NO 872541A NO 872541 A NO872541 A NO 872541A NO 872541 D0 NO872541 D0 NO 872541D0
Authority
NO
Norway
Prior art keywords
procedure
manufacturing
immuno modulators
immuno
modulators
Prior art date
Application number
NO872541A
Other languages
English (en)
Other versions
NO872541L (no
Inventor
Andre Lefesvre
Original Assignee
New Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Therapeutics Ltd filed Critical New Therapeutics Ltd
Publication of NO872541D0 publication Critical patent/NO872541D0/no
Publication of NO872541L publication Critical patent/NO872541L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO872541A 1986-06-17 1987-06-17 FremgangsmŸte ved fremstilling av immunomodulatorer. NO872541L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868614733A GB8614733D0 (en) 1986-06-17 1986-06-17 Aids treatment

Publications (2)

Publication Number Publication Date
NO872541D0 true NO872541D0 (no) 1987-06-17
NO872541L NO872541L (no) 1987-12-18

Family

ID=10599595

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872541A NO872541L (no) 1986-06-17 1987-06-17 FremgangsmŸte ved fremstilling av immunomodulatorer.

Country Status (11)

Country Link
EP (1) EP0250234A1 (no)
JP (1) JPS6360932A (no)
AU (1) AU7441587A (no)
CH (1) CH673396A5 (no)
DE (1) DE3720434A1 (no)
DK (1) DK308687A (no)
FR (1) FR2599971B1 (no)
GB (2) GB8614733D0 (no)
IL (1) IL82893A0 (no)
NO (1) NO872541L (no)
PT (1) PT85115A (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
DE3827490A1 (de) * 1988-08-12 1990-02-15 Hor Fer Vit Pharma Gmbh Herrichtung und verwendung eines physiologisch aktiven polypeptids zur aids-therapie
EP0537722A3 (en) * 1991-10-15 1994-07-13 Kremers Urban Co Porcane liver polypeptides for treating viral infections
AU2003295395A1 (en) * 2002-11-04 2004-06-07 4Life Research, Lc Compositions, systems, and methods for focusing a cell-mediated immune response

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073293B1 (no) * 1969-12-31 1973-01-12 Pasteur Institut
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
GB1443948A (en) * 1972-10-20 1976-07-28 Piktor Ltd Production of immunological material
GB1592954A (en) * 1976-12-16 1981-07-15 Int Inst Of Differentiation Cell line
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4180627A (en) * 1978-08-17 1979-12-25 The United States Of America As Represented By The Secretary Of Agriculture Process for in vivo transfer of cell-mediated immunity in mammals with alcoholic precipitates of Bovine Transfer factor
NO793412L (no) * 1978-10-25 1980-05-06 Benzon As Alfred Fremgangsmaate for fremstilling av overfoeringsfaktor mot patogene antigener
FI78483C (fi) * 1980-05-14 1989-08-10 A Arthur Gottlieb Rening av modulatorer foer immunsystem.
US4323555A (en) * 1980-11-03 1982-04-06 The Regents Of The University Of California Method of protecting cattle and sheep against bovine leukemia virus and vaccines for use therein
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
JPS5967226A (ja) * 1982-07-20 1984-04-16 デイミトリ・ビザ ウイルス感染処置に使用する転移因子
US4521407A (en) * 1983-08-29 1985-06-04 Serono Pharmaceutical Partners Treatment of acquired immune deficiency syndrome with thymus extract
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens

Also Published As

Publication number Publication date
IL82893A0 (en) 1987-12-20
NO872541L (no) 1987-12-18
GB8714181D0 (en) 1987-07-22
DK308687A (da) 1987-12-18
JPS6360932A (ja) 1988-03-17
PT85115A (en) 1987-07-01
AU7441587A (en) 1987-12-24
FR2599971B1 (fr) 1990-11-30
GB2193498A (en) 1988-02-10
DE3720434A1 (de) 1987-12-23
EP0250234A1 (en) 1987-12-23
DK308687D0 (da) 1987-06-17
GB8614733D0 (en) 1986-07-23
CH673396A5 (no) 1990-03-15
FR2599971A1 (fr) 1987-12-18

Similar Documents

Publication Publication Date Title
NO903190L (no) Fremgangsmaate for klorering av sukrose-b-estere.
NO842394L (no) Fremgangsmaate ved fremstilling av 13alfa-alkylgonamer.
NO170071C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO870395L (no) Fremgangsmaate ved utvinning av gallium.
NO880396D0 (no) Fremgangsmaate ved fremstilling av papir.
NO166032C (no) Fremgangsmaate ved fremstilling av triklormonosilan.
NO166416C (no) Fremgangsmaate ved fremstilling av cellulosemasse.
NO854657L (no) Fremgangsmaate ved fremstilling av isosilybinfri silibin.
NO884665L (no) Fremgangsmaate ved fremstilling av 9-oh-alkoksyguanin.
NO892068D0 (no) Fremgangsmaate ved fremstilling av naftatiozepinoner.
NO872156D0 (no) Fremgangsmaate ved opparbeidelse av batterier.
NO874557D0 (no) Fremgangsmaate ved fremstilling av urea.
NO165678C (no) Fremgangsmaate ved fremstilling av et polysyklisk eterantibiotikum.
NO890514D0 (no) Fremgangsmaate ved fremstilling av urea.
NO872541D0 (no) Fremgangsmaate ved fremstilling av immunomodulatorer.
NO851386L (no) Fremgangsmaate for fremstilling av antigen.
NO880333L (no) Fremgangsmaate ved fremstilling av natriumkarboksymetyl-cellulose.
NO168864C (no) Fremgangsmaate for dekaffeinering av raakaffe.
NO872690L (no) FremgangsmŸte for fremstilling av mercaptoacylprolin.
NO880100L (no) Fremgangsmaate ved utskiftning av anoder.
NO870828L (no) FremgangsmŸte for fremstilling av biskarbamater.
NO875403D0 (no) Fremgangsmaate ved fremstilling av poelse.
NO159250C (no) Fremgangsmaate ved fremstilling av jernbanehjul.
NO874958D0 (no) Fremgangsmaate for fremstilling av 1-aryloksy-3-amino-2-propanoler.
NO891898D0 (no) Fremgangsmaate ved fremstilling av naftotiazepinoner.